Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1352328-67-6

Post Buying Request

1352328-67-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (R)-Benzyl 4-((3R,5R,7S,8S,9S,10R,13R,14S,17R,E)-6-ethylidene-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate,

    Cas No: 1352328-67-6

  • No Data

  • No Data

  • 1/100 Kilogram/Day

  • Shanghai Hope Chem Co., Ltd
  • Contact Supplier

1352328-67-6 Usage

Description

Benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate is a bile acid derivative characterized by the presence of hydroxyl groups at the 3α and 7α positions, an ethyliden substituent at the 6 position, and an ester linkage at the 24 position. Its unique structure and arrangement of carbon atoms in the steroid ring system contribute to its biological activity, making it a promising candidate for pharmaceutical or medical applications.

Uses

Used in Pharmaceutical Industry:
Benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate is used as a pharmaceutical compound for its potential physiological effects. The specific functional groups and the arrangement of carbon atoms in its steroid ring system may contribute to its therapeutic properties, making it a valuable asset in the development of new drugs.
Used in Medical Industry:
In the medical field, benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate may be utilized for its potential applications in treating various health conditions. Its unique structure and biological activity could be harnessed to develop targeted therapies or diagnostic tools, enhancing patient care and outcomes.
Used in Drug Development:
Benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate is used as a key component in drug development, where its unique structure and functional groups can be leveraged to create novel therapeutic agents. Researchers can explore its potential in modulating biological pathways or targeting specific receptors, leading to the discovery of new treatments for various diseases.
Used in Diagnostic Applications:
In the diagnostic industry, benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate may be employed as a biomarker or a component in diagnostic assays. Its unique properties could be utilized to detect or monitor certain health conditions, providing valuable insights for clinicians and patients alike.
Used in Nutritional Supplements:
Given its role in the digestion and absorption of dietary fats, benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate may also find applications in the development of nutritional supplements. It could be incorporated into formulations to support healthy digestion and enhance the bioavailability of fat-soluble nutrients.

Check Digit Verification of cas no

The CAS Registry Mumber 1352328-67-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,3,2 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1352328-67:
(9*1)+(8*3)+(7*5)+(6*2)+(5*3)+(4*2)+(3*8)+(2*6)+(1*7)=146
146 % 10 = 6
So 1352328-67-6 is a valid CAS Registry Number.

1352328-67-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 3α,7α-dihydroxy-6-ethyliden-5β-cholan-24-oate

1.2 Other means of identification

Product number -
Other names OCA-G1

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1352328-67-6 SDS

1352328-67-6Downstream Products

1352328-67-6Relevant articles and documents

Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge Theonella swinhoei

Sepe, Valentina,Ummarino, Raffaella,Dauria, Maria Valeria,Chini, Maria Giovanna,Bifulco, Giuseppe,Renga, Barbara,Damore, Claudio,Debitus, Cécile,Fiorucci, Stefano,Zampella, Angela

, p. 84 - 93 (2012)

We report the isolation and pharmacological characterization of conicasterol E isolated from the marine sponge Theonella swinhoei. Pharmacological characterization of this steroid in comparison to CDCA, a natural FXR ligand, and 6-ECDCA, a synthetic FXR agonist generated by an improved synthetic strategy, and rifaximin, a potent PXR agonist, demonstrated that conicasterol E is an FXR modulator endowed with PXR agonistic activity. Conicasterol E induces the expression of genes involved in bile acids detoxification without effect on the expression of small heterodimer partner (SHP), thus sparing the expression of genes involved in bile acids biosynthesis. The relative positioning in the ligand binding domain of FXR, explored through docking calculations, demonstrated a different spatial arrangement for conicasterol E and pointed to the presence of simultaneous and efficient interactions with the receptor. In summary, conicasterol E represents a FXR modulator and PXR agonist that might hold utility in treatment of liver disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1352328-67-6